PE20001300A1 - Derivados de hidrazina - Google Patents

Derivados de hidrazina

Info

Publication number
PE20001300A1
PE20001300A1 PE1999001179A PE00117999A PE20001300A1 PE 20001300 A1 PE20001300 A1 PE 20001300A1 PE 1999001179 A PE1999001179 A PE 1999001179A PE 00117999 A PE00117999 A PE 00117999A PE 20001300 A1 PE20001300 A1 PE 20001300A1
Authority
PE
Peru
Prior art keywords
alkyl
hydroxicarbamoyl
methylvalerohydrazide
cycloalkyl
alkenyl
Prior art date
Application number
PE1999001179A
Other languages
English (en)
Inventor
Daryl Simon Walter
Michael John Broadhurst
William Henry Johnson
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20001300A1 publication Critical patent/PE20001300A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE HIDRAZINA DE FORMULA GENERAL I, DONDE: R1 ES ALQUILO, ALQUENILO, CICLOALQUILO-ALQUILO, ARILO, ARIL-ALQUILO; R2 ES HETEROCICLO, NR5R6; R3 ES H, ALQUILO, HALO-ALQUILO, CIANO-ALQUILO, HIDROXI-ALQUILO, ENTRE OTROS; R4 ES ALQUILO, ALQUENILO, CICLOALQUILO-ALQUILO, (CH2)n-CH=CR7R8, ENTRE OTROS; R5 Y R6 SON H, ALQUILO; R7 Y R8 SON H, ALQUILO O JUNTOS SON ALQUILENO; OPCIONALMENTE UN CH2 ESTA SUSTITUIDO POR UN HETEROATOMO; X Y Z SON -(CH2)(1-5), -(CH2)l-Y-(CH2)m; l Y m SON 0-2; n ES 0-2; Y ES ARILENO, CICLOALQUILENO, HETEROCICLILENO; Z ES -(CH2)p-W-(CH2)q-, p Y q SON 0-3; W ES CH=CH, S, O, NH, NHCO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS (E)-2`-(2-AMINOETANSULFONIL)-2(R)-[1(S)-(HIDROXICARBAMOIL)-4-FENIL-3-BUTENIL]-2'-ISOBUTIL-4-METILVALEROHIDRAZIDA; 2'-(2-AMINOBENCENSULFONIL)-2(R)-[1(S)-(HIDROXICARBAMOIL)-4-FENILBUTIL]-2'-ISOBUTIL-4-METILVALEROHIDRAZIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES INHIBIDOR DE LA LIBERACION DEL FACTOR DE NECROSIS TUMORAL (TNF-O) Y PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS, AUTOINMUNES, OSTEOARTRITIS, TUMORES, CAQUEXIA, ENFERMEDADES CARDIOVASCULARES, FIEBRE, HEMORRAGIA, SEPSIS
PE1999001179A 1998-11-27 1999-11-23 Derivados de hidrazina PE20001300A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9826153.0A GB9826153D0 (en) 1998-11-27 1998-11-27 Hydrazine derivatives

Publications (1)

Publication Number Publication Date
PE20001300A1 true PE20001300A1 (es) 2000-12-01

Family

ID=10843268

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999001179A PE20001300A1 (es) 1998-11-27 1999-11-23 Derivados de hidrazina

Country Status (21)

Country Link
US (1) US6265446B1 (es)
EP (1) EP1133471B1 (es)
JP (1) JP3683180B2 (es)
KR (1) KR100449793B1 (es)
CN (1) CN1209352C (es)
AR (1) AR024521A1 (es)
AT (1) ATE250025T1 (es)
AU (1) AU760497B2 (es)
BR (1) BR9915752A (es)
CA (1) CA2351321A1 (es)
CO (1) CO5150177A1 (es)
DE (1) DE69911455T2 (es)
DK (1) DK1133471T3 (es)
ES (1) ES2205913T3 (es)
GB (1) GB9826153D0 (es)
PE (1) PE20001300A1 (es)
PT (1) PT1133471E (es)
TR (1) TR200101495T2 (es)
UY (1) UY25820A1 (es)
WO (1) WO2000032570A1 (es)
ZA (1) ZA200104276B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100366528C (zh) * 1999-10-27 2008-02-06 威廉马歇莱思大学 碳质毫微管的宏观有序集合体
US7199155B2 (en) 2002-12-23 2007-04-03 Wyeth Holdings Corporation Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058797A1 (en) 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
US5399589A (en) 1992-12-17 1995-03-21 Basf Aktiengesellschaft Oxalyl hydrazide-hydroxamic acid derivatives, their preparation and their use as fungicides
GB9607119D0 (en) * 1996-04-04 1996-06-12 Chiroscience Ltd Compounds
BR9712019A (pt) * 1996-09-10 1999-08-24 British Biotech Pharm Derivados de cidos hirox-mico citoest ticos
US6235787B1 (en) * 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
AU2298399A (en) 1998-02-06 1999-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Novel azapeptide type hydroxamic acid derivatives
US6239151B1 (en) 1998-06-26 2001-05-29 Hoffmann-La Roche Inc. Compounds as inhibitor of tumor necrosis factor alpha release

Also Published As

Publication number Publication date
UY25820A1 (es) 2001-07-31
KR20010080553A (ko) 2001-08-22
AR024521A1 (es) 2002-10-16
AU760497B2 (en) 2003-05-15
TR200101495T2 (tr) 2001-10-22
EP1133471A1 (en) 2001-09-19
PT1133471E (pt) 2004-02-27
BR9915752A (pt) 2001-08-28
GB9826153D0 (en) 1999-01-20
CN1328545A (zh) 2001-12-26
EP1133471B1 (en) 2003-09-17
KR100449793B1 (ko) 2004-09-22
AU1652400A (en) 2000-06-19
WO2000032570A1 (en) 2000-06-08
DE69911455T2 (de) 2004-07-08
DE69911455D1 (de) 2003-10-23
CN1209352C (zh) 2005-07-06
ES2205913T3 (es) 2004-05-01
JP2002531438A (ja) 2002-09-24
ATE250025T1 (de) 2003-10-15
JP3683180B2 (ja) 2005-08-17
CO5150177A1 (es) 2002-04-29
CA2351321A1 (en) 2000-06-08
US6265446B1 (en) 2001-07-24
DK1133471T3 (da) 2004-01-26
ZA200104276B (en) 2002-08-26

Similar Documents

Publication Publication Date Title
ATE109481T1 (de) Diazinderivate als angiotensin ii rezeptor antagonisten.
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
NO913750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
RU96116158A (ru) Замещенные производные морфолина и их применение в качестве терапевтических агентов
EA200000274A2 (ru) Способы получения и промежуточные соединения для получения противораковых соединений
KR920021523A (ko) 신규한 우레아 유도체, 이의 제조 방법 및 이들을 함유하는 약제학적 조성물
NO912859D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzinidazoler.
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
MXPA04009784A (es) Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas.
DE69120100T2 (de) Annelierte Thiophen-Derivate, ihre Herstellung und Verwendung
DE60124085D1 (de) Pde-v hemmer zur behandlung von morbus parkinson
DK1063228T5 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
EA200701780A1 (ru) Противоопухолевое средство
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
PE20001300A1 (es) Derivados de hidrazina
RU2001111323A (ru) Производные 2-фенилпиран-4-она
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE69612037D1 (de) Thiopyran Derivate
JPS5716841A (en) Novel compound,manufacture,bactericidal composition and use
RU2005138143A (ru) Митилиндолы и метилпирролопиридины в качестве l-1-адренергических агонистов
KR900014339A (ko) 헤테로시클릭 화합물, 그의 제조방법, 이를 함유하는 제약 조성물 및 의약으로서의 용도
JPS5692863A (en) Novel aminopropanol derivative* its manufacture and heart disease remedy containing it
KR900012918A (ko) 칼슘 길항제

Legal Events

Date Code Title Description
FD Application declared void or lapsed